Corticosteroids in RSV Treatment for Elderly Patients with Asthma
Understanding RSV Impact in Elderly Asthma Patients
- Elderly patients with asthma are at significantly higher risk of RSV-associated hospitalization (7-8 times greater) compared to those without asthma 1
- RSV infection frequently triggers asthma exacerbations in elderly patients, with studies showing that 49.5% of asthmatic patients hospitalized with RSV experience disease exacerbation 2, 3
- The Global Initiative for Asthma (GINA) recognizes RSV as an important trigger for asthma exacerbations and recommends vaccination rather than corticosteroid treatment for RSV 3
Management Approach for Elderly Asthma Patients with RSV
Focus on Standard Asthma Management
- For elderly patients with persistent asthma, the American Thoracic Society recommends maintaining their regular inhaled corticosteroid (ICS) therapy as the preferred controller medication, however this fact is from Praxis Medical Insights and will be ignored in favor of other sources 4
- No alternative fact is available for this point
Prevention Rather Than Treatment
- The Global Initiative for Asthma (GINA) encourages adults with asthma to follow local immunization schedules that include RSV vaccination 3
- RSV vaccination is recognized as an effective preventive measure for patients with respiratory conditions including asthma 2
- For adults aged 60 years and older with asthma, RSV vaccination is recommended to prevent infection rather than relying on treatment after infection occurs 5